A one-day event showcasing the latest cutting-edge research on the modelling, biology and treatment of paediatric cancers in the context of their developmental origins.
The aim of the meeting is to bring together researchers at the interface of stem cell, developmental and cancer biology with translational and clinical researchers in order to foster exchange of ideas, collaborations and networking opportunities.
Major themes include:
- Development of novel in vitro and in vivo models of paediatric cancers and insights gained from their use
- Risk factors/genetic drivers
- Tumour dependencies and implications for therapy
Book of abstracts
Further information about the symposium
- Florian Halbritter, CCRI, Vienna: Developmental state shapes EWS::FLI1 fusion oncogene effects during human mesenchymal differentiation
- Chris Jones, ICR, London: Lineage, cell state and plasticity defining drug sensitivity and resistance in paediatric-type diffuse high-grade glioma
- Majlinda Lako, Newcastle University: Targeting Retinoblastoma: Drug Repurposing in Patient-Specific Retinal Models
- Katrin Ottersbach, University of Edinburgh: Modelling paediatric tumour development – in vivo models
- Ruth Palmer, University of Gothenburg: Targeting ALK in neuroblastoma – considering the potential importance of developmental context (sponsored by Neuroblastoma UK)
- Steve Pollard, University of Edinburgh: Turning cancer against itself: programmable gene therapy for glioblastoma
- John Anderson, UCL, London
- James Briscoe, The Francis Crick Institute, London
- Sally George, ICR, London
- Karen Liu, KCL, London
- Anestis Tsakiridis, University of Sheffield
- Deborah Tweddle, Newcastle University
Book your place today
We gratefully acknowledge the support of:
Neuroblastoma UK